Dolby Laboratories (NYSE:DLB) Updates Q2 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its second quarter 2025 earnings guidance on Wednesday. The company provided EPS guidance of 1.190-1.340 for the period, compared to the consensus EPS estimate of 1.350. The company issued revenue guidance of $355.0 million-$385.0 million, compared to the consensus revenue estimate of $387.2 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Price Performance

Dolby Laboratories stock traded up $7.10 during trading hours on Thursday, reaching $87.73. The stock had a trading volume of 180,088 shares, compared to its average volume of 435,043. The company has a fifty day simple moving average of $79.15 and a 200-day simple moving average of $75.65. Dolby Laboratories has a 52 week low of $66.35 and a 52 week high of $88.11. The stock has a market cap of $8.37 billion, a PE ratio of 32.34 and a beta of 0.98.

Dolby Laboratories Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd were issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date of this dividend was Tuesday, December 3rd. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.30. Dolby Laboratories’s payout ratio is currently 48.71%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Rosenblatt Securities reiterated a “buy” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday. Barrington Research reiterated an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Monday. Finally, StockNews.com raised shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, December 4th.

Insiders Place Their Bets

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 12,338 shares of the company’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $78.08, for a total value of $963,351.04. Following the sale, the executive vice president now owns 62,397 shares in the company, valued at approximately $4,871,957.76. This represents a 16.51 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Kevin J. Yeaman sold 50,000 shares of Dolby Laboratories stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $80.54, for a total transaction of $4,027,000.00. Following the transaction, the chief executive officer now owns 83,721 shares of the company’s stock, valued at $6,742,889.34. The trade was a 37.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 135,917 shares of company stock worth $10,877,739. Company insiders own 38.39% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.